1-12 of 12
Dana Yehudai
Close
Sort by
Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation with Treosulfan -Fludarabine and Busulfan-Fludarabine Conditioning Have Similar Efficacy in Patients ≥65 Years Old or Those with Comorbidities

Israel J. Henig, Ohad Geller, Dana Yehudai-Ofir, Baher Krayem, Avraham Frisch, Hazim Khatib, Tsila Zuckerman
Journal: Blood
Blood (2023) 142 (Supplement 1): 2166.
https://doi.org/10.1182/blood-2023-180721
Published: 2023
Journal Articles

Soluble LAG3: A Potential Marker for the Development and Activity of Acute Graft-Versus-Host Disease

Dana Yehudai-Ofir, Nasren Eiza, Israel J. Henig, Tsila Zuckerman, Zahava Vadasz
Journal: Blood
Blood (2023) 142 (Supplement 1): 4795.
https://doi.org/10.1182/blood-2023-184496
Published: 2023
Journal Articles

Response Rates of Extra-Nodal Diffuse Large B Cell Lymphoma to CD19-CAR T Cells - a Real Word Retrospective Multi-Center Study

Ofrat Beyar Katz, Chava Perry, Efrat Luttwak, Inbal Sdayoor, Yael Bar-On, Odelia Amit, Ronit Gold, Yair Herishanu, Noam Benyamini, Sigal Grisariu Greenzaid, Batia Avni, Polina Stepensky, Diana Libster, Dana Yehudai-Ofir, Shimrit Harlev, Liat Sharvit, Tsila Zuckerman, Uri Greenbaum, Irit Avivi, Ron Ram
Journal: Blood
Blood (2022) 140 (Supplement 1): 3816–3817.
https://doi.org/10.1182/blood-2022-165149
Published: 2022
Journal Articles

Letermovir Prophylaxis for High-Risk Allogenic Transplantation Recipients, Real- World Israeli Experience

Sigal Grisariu Greenzaid, Ron Ram, Mona Kazuli, Dana Yehudai-Ofir, Liat Shargian, Tsila Zuckerman, Moshe Yeshurun, Odelia Amit, Yael Bar-On, Eran Zimran, Adir Shaulov, Polina Stepensky, Jacob Strahilevitz, Batia Avni
Journal: Blood
Blood (2022) 140 (Supplement 1): 12833–12834.
https://doi.org/10.1182/blood-2022-164694
Published: 2022
Journal Articles

A Comprehensive Toxicity and Efficacy Analysis of Different Bridging Therapies Prior to Anti CD19-CAR-T Cell Therapy in Patients with DLBCL- a National Multi-Center Cohort Study

Ron Ram, Sigal Grisariu, Liat Shargian-Alon, Dana Yehudai-Ofir, Irit Avivi, Orit Gutfeld, Polina Stepensky, Tsila Zuckerman, Moshe Yeshurun, Odelia Amit, Batia Avni, Ronit Gurion, Yael Bar-On, Ofrat Beyar-Katz, Ronit Gold, Shimrit Ringelstein, Itai Levi, Tzvi Porges, Chava Perry
Journal: Blood
Blood (2021) 138 (Supplement 1): 1733.
https://doi.org/10.1182/blood-2021-151085
Published: 2021
Journal Articles

Safety and Preliminary GvHD Mitigation in First in Human Clinical Trial of Apograft in Match Related Stem Cell Transplantation (SCT)

Tsila Zuckerman, Polina Stepensky, Dana Yehudai-Ofir, Israel Henig, Moshe Kamar, Jerry Stein
Journal: Blood
Blood (2021) 138 (Supplement 1): 2893.
https://doi.org/10.1182/blood-2021-149419
Published: 2021
Journal Articles

Omitting Fluoroquinolones Antibiotic Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation Does Not Increase Gram-Negative Bacteremia Rate or Transplant-Related Mortality

Israel Henig, MD, Oryan Henig, Haggai Bar-Yoseph, Hanin Daoud, Dana Yehudai-Ofir, MD, Ilana Oren, Tsila Zuckerman, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 34–35.
https://doi.org/10.1182/blood-2020-142357
Published: 2020
Journal Articles

NPM1 Quantitative Monitoring of Minimal Residual Disease in Acute Myeloid Leukemia Allows More Precise Selection of Patients for Allogeneic Stem Cell Transplantation without Affecting Their Survival

Yishai Ofran, MD, Ronit Leiba, Dina Rosenberg, Israel Henig, MD, Dana Yehudai-Ofir, MD, Nuhad Haddad, MD, Riva Fineman, MD, Avraham Frisch, MD, Doaa Okasha, MD, Yariv Carasso, MD, Tsila Zuckerman, MD, Nurit Horesh, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2603.
https://doi.org/10.1182/blood-2019-126553
Published: 2019
Journal Articles

Radiation-Free Protocol for Patients with Acute Lymphoblastic Leukemia and Mixed Phenotype Acute Leukemia Undergoing Induction Chemotherapy and Allogeneic Hematopoietic Cell Transplantation - a Multicenter Historical Prospective Study

Odelia Amit, MD, Yael Bar-On, MD, Irit Avivi, Tsila Zuckerman, MD, Galit Perets, MD, Israel Henig, MD, Itai Levi, MD, Dana Yehudai-Ofir, MD, Shimrit Ringelstein Harlev, MD, Ron Ram, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5654.
https://doi.org/10.1182/blood-2019-128248
Published: 2019
Journal Articles

The Thymidine Dideoxynucleoside Analogue, Alovudine, Inhibits the Mitochondrial DNA Polyermase, POLG, Impairs Oxidative Phosphorylation and Promotes Monocytic Differentiation in AML

Dana Yehudai-Ofir, MD, Sanduni U. Liyanage, Hon. B. Sc, PhD, Rose Hurren, BSc, Marcela Gronda, MSc, Danny V. Jeyaraju, PhD, Xiaoming Wang, Thirushi Siriwardena, Yulia Jitkova, PhD, Aaron D. Schimmer, MDPhD, Biljana Rizoska, PhD, Paul Targett-Adams, PhD, Mark Albertella, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2524.
https://doi.org/10.1182/blood.V130.Suppl_1.2524.2524
Published: 2017
Journal Articles

Leveraging increased cytoplasmic nucleoside kinase activity to target mtDNA and oxidative phosphorylation in AML

Sanduni U. Liyanage, Rose Hurren, Veronique Voisin, Gaëlle Bridon, Xiaoming Wang, ChangJiang Xu, Neil MacLean, Thirushi P. Siriwardena, Marcela Gronda, Dana Yehudai, Shrivani Sriskanthadevan, Daina Avizonis, Aisha Shamas-Din, Mark D. Minden, Gary D. Bader, Rebecca Laposa, Aaron D. Schimmer
Journal: Blood
Blood (2017) 129 (19): 2657–2666.
https://doi.org/10.1182/blood-2016-10-741207
Published: 2017
Includes: Supplemental data
Journal Articles

Autologous Stem Cell Transplantation in Favorable Acute Myeloid Leukemia Is Associated with a Better Long-Term Prognosis: a Single Center Experience

Ofrat Beyar-Katz, MD, Israel Henig, MD, Dana Yehudai, MD, Nov Yuval, MSc, Riva Fineman, MD, Nuhad Haddad, MD, Yishai Ofran, MD, Jacob M. Rowe, MD, Tsila Zuckerman, MD
Journal: Blood
Blood (2016) 128 (22): 5819.
https://doi.org/10.1182/blood.V128.22.5819.5819
Published: 2016